Provided By PR Newswire
Last update: May 22, 2025
Real-World Analysis Shows Statistically Significant Reduction in Severe Bleeding and Transfusion Needs in CABG Patients on the Blood Thinner, Ticagrelor, with CytoSorbents Therapy
Read more at prnewswire.com0.9434
+0.01 (+0.84%)
Find more stocks in the Stock Screener